<DOC>
	<DOCNO>NCT00775580</DOCNO>
	<brief_summary>The purpose study determine bioequivalence atenolol formulation administration single dos normal healthy subject fast condition . These data evaluate statistically determine product meet bioequivalence criterion .</brief_summary>
	<brief_title>Bioequivalence Study Atenolol 100mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>The study conduct open label , balance , randomise , two-treatment , two-period , two-sequence , single-dose , crossover , bioequivalence study atenolol compare atenolol 100mg tablet Ranbaxy Tenormin 100mg capsule healthy , adult , human , subject fast condition . A total 36 non-smoking subject ( 26 men 10 woman ) include study , 35 finish study accord protocol ,</detailed_description>
	<mesh_term>Atenolol</mesh_term>
	<criteria>1 . Healthy subject least 18 year age . 2 . Informed nature study give write informed consent . 3 . Have body weight within 15 % appropriate range define 1983 Metropolitan Life Company table weigh least 110 pound . 1 . Hypersensitivity Atenolol ( Tenormin® ) relate compound propranolol ( Inderal® ) . 2 . Conditions affect absorption , metabolism passage drug body , e.g. , sprue , celiac disease , Crohn 's disease , colitis , liver , kidney thyroid condition . 3 . Recent history ( within one year ) mental illness , drug addiction , drug abuse alcoholism . 4 . Donation great 500 ml blood past 4 week prior study dose difficulty donate blood . 5 . Received investigational drug within 4 week prior study dose . 6 . Currently take prescription medication , except oral contraceptive , within 7 day prior study dose overthecounter medication within 3 day study dose . This prohibition include vitamin herbal preparation take nutritional supplement nontherapeutic indication judge attend physician . Any nonprescription medication consumption report review investigator ( ) prior dose . At discretion investigator ( ) , volunteer may enrol medication anticipate alter study integrity . 7 . Regular smoke 5 cigarette daily daily use nicotinecontaining product begin 3 month study medication administration final evaluation . 8 . If female , subject lactate positive pregnancy test screen prior treatment period . Females must use medically acceptable method contraception throughout entire study period one week study complete . Medically acceptable method contraception may use subject and/or partner : oral contraceptives/patches , progestin injection implant , condom spermacide , diaphragm spermacide , IUD , vaginal spermicidal/hormonal suppository , surgical sterilization partner ( ) abstinence . Females take oral contraceptive must take consistently least three month prior receive study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>bioequivalence Atenolol Tablets</keyword>
</DOC>